Another small little spot that is red and tender on the back side of arm toward back; Another small little spot that is red and tender on the back side of arm toward back; Injection site hot; Injection site red; Injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE SWELLING (Injection site swollen), ERYTHEMA (Another small little spot that is red and tender on the back side of arm toward back) and TENDERNESS (Another small little spot that is red and tender on the back side of arm toward back) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE SWELLING (Injection site swollen). On 23-Jan-2021, the patient experienced ERYTHEMA (Another small little spot that is red and tender on the back side of arm toward back) and TENDERNESS (Another small little spot that is red and tender on the back side of arm toward back). At the time of the report, VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE SWELLING (Injection site swollen), ERYTHEMA (Another small little spot that is red and tender on the back side of arm toward back) and TENDERNESS (Another small little spot that is red and tender on the back side of arm toward back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE SWELLING (Injection site swollen), ERYTHEMA (Another small little spot that is red and tender on the back side of arm toward back) and TENDERNESS (Another small little spot that is red and tender on the back side of arm toward back) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red) and VACCINATION SITE SWELLING (Injection site swollen). On 23-Jan-2021, the patient experienced ERYTHEMA (Another small little spot that is red and tender on the back side of arm toward back) and TENDERNESS (Another small little spot that is red and tender on the back side of arm toward back). At the time of the report, VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE SWELLING (Injection site swollen), ERYTHEMA (Another small little spot that is red and tender on the back side of arm toward back) and TENDERNESS (Another small little spot that is red and tender on the back side of arm toward back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported.